MAPT and Alzheimer disease: Female APOE4 carriers with MCI or mild AD exhibit a higher burden of AD pathology, as well as greater CSF tau and tau/Aβ ratios than male APOE4 carriers with the same diagnosis [8, 9, 14, 62].